Sestina Bio

Sestina Bio, LLC is a synthetic biology company based in Pleasanton, California, founded in 2020. After being acquired by Inscripta, Inc. in January 2023, Sestina Bio focuses on developing a synthetic biology platform that combines genome editing, single cell biology, and machine learning. This platform enables the efficient engineering of biological functions and the creation of biological strains suitable for large-scale manufacturing. The company leverages ultra-high throughput single cell technologies to generate extensive data sets, allowing for precise biological engineering. Sestina Bio aims to provide sustainable solutions for feeding, clothing, and treating the global population. Its services support clients in agriculture, healthcare, and industrial biotechnology, fostering deep partnerships to meet diverse market needs. As part of Inscripta, Sestina Bio enhances the capabilities in automated genome engineering and biological research tools.

Research Pleasanton, United States ~2 employees Private · Series E

Work at Sestina Bio in HR or recruiting? Claim this page

Employees
2
0% in the 3 months to Jun 2025
Revenue / employee
$5.4M
Revenue ~$10.8M
Total funding
$383M
Last round Series E, Apr 2021
12-month attrition
171.4%
H1B sponsor
NA

Headcount trend

Sestina Bio went from 1 employees in Jul 2023 to 0 in Jun 2025.

Headcount data through Jun 2025

Funding rounds

Total funding$383M
Funding rounds5
Investors12

Sestina Bio FAQ

How many employees does Sestina Bio have?

Sestina Bio has about 2 employees, unchanged over the 3 months to Jun 2025.

What is Sestina Bio's revenue per employee?

Sestina Bio makes about $5.4M in revenue per employee, based on $10.8M annual revenue and 2 employees.

How much funding has Sestina Bio raised?

Sestina Bio has raised $383M in total funding; its latest round was Series E in Apr 2021.

Data from Company Prospectus, DOL LCA disclosures, WARN notices and 6figr salary profiles.